Analystreport

Viking Therapeutics (NASDAQ:VKTX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $125.00 price target on the stock.

Viking Therapeutics, Inc.  (VKTX) 
Last viking therapeutics, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vikingtherapeutics.com